RIL
TNGX icon

Rothschild Investment LLC’s Tango Therapeutics TNGX Stock Holding History

Rothschild Investment LLC’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.8K Buy
86
+60
+231% +$835 ﹤0.01% 2603
2025
Q4 		$230 Buy
26
+6
+30% +$52 ﹤0.01% 3092
2025
Q3 		$168 Buy
+20
New +$135 ﹤0.01% 3023
2025
Q1 		– Sell
-40
Closed -$124 – 3090
2024
Q4 		$124 Sell
40
-55
-58% -$255 ﹤0.01% 2884
2024
Q3 		$732 Buy
95
+65
+217% +$620 ﹤0.01% 2354
2024
Q2 		$257 Buy
+30
New +$232 ﹤0.01% 2380

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Rothschild Investment LLC's TNGX Position: Q1 2026 in Review

Rothschild Investment LLC increased its Tango Therapeutics (TNGX) stake by 231% in Q1 2026, buying an estimated $835 and bringing the position to 86 shares worth $1.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2603.

Rothschild Investment LLC first reported a position in TNGX in Q2 2024 and has held it in 6 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Rothschild Investment LLC held 86 shares of Tango Therapeutics worth $1.8K as of Q1 2026.
  • Rothschild Investment LLC bought 60 Tango Therapeutics shares in Q1 2026, an estimated $835.
  • Tango Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #2603 holding.
  • Rothschild Investment LLC first reported a position in Tango Therapeutics in Q2 2024 and has held it in 6 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.